News – Page 644 – Endpoints News

Recall report: Amino acid IV pulled after hair, other foreign substances found in batch

4 years ago

Roche to buy up diagnostics partner TIB Molbiol; PAQ to partner with Insilico

4 years ago

A new player joins the RNA editing race on the heels of Eli Lilly's $1B-plus deal

4 years ago

As Delta takes control, US resumes use of Lilly's Covid-19 mAb combo nationwide

4 years ago

Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug

4 years ago

Struggling Acorda team brings out the axe — yet again — to chop away at costs as sales sputter

4 years ago

Exclusive: Prison and multibillion dollar buyouts later, Sam Waksal is all in on the biotech game, with some big-name ...

4 years ago

Jennifer Doudna's diagnostic spinout raises Mammoth round as it expands to therapies

4 years ago

Ionis collaborator Flamingo is ready to take flight with 3 antisense drugs in the clinic and mysterious RNA in its ...

4 years ago

A new clutch of biotech blue-chippers joins Obsidian's quest to craft next-gen drugs with an 'on' switch

4 years ago

Medicxi's mega-startup Centessa rolls out first data for hemophilia drug with plans to charge ahead into pivotal test

4 years ago

After getting their candidates back from Eli Lilly, the old Dermira team is dashing for the clinic

4 years ago

Eli Lilly-backed Lycia fuels up on VC cash in a discovery drive toward protein degradation 2.0

4 years ago

The Tachi Yamada legacy tree continues to grow with a new gene editing biotech from Jim Wilson

4 years ago

Humanigen crashes as FDA shoots down its Covid-19 drug EUA

4 years ago

A top pick in Paul Hudson's campaign to revive the pipeline at Sanofi blows up in PhIII

4 years ago

Ronald Crystal's Lexeo Therapeutics pulls in a $100M megaround just nine months after launch

4 years ago

Eli Lilly bets on an RNA base editing outfit leveraging the body's own enzymes to reverse mutations

4 years ago

Top biopharma execs offer scare tactics and mixed messages on drug pricing bills making their way to Capitol Hill

4 years ago

A few months into his new role at Attralus, ex-Purdue chief Mark Timney leads the biotech to a $116M round

4 years ago

Looking for fresh start following a Duchenne disaster, Catabasis rebrands; Huadong and Insilico team up in oncology

4 years ago

Covid-19 roundup: Gates Foundation, Exscientia team up on pandemic antiviral discovery pact; Novavax opens trial for ...

4 years ago

Months after landing Canadian site from government, Resilience announces a big mRNA partner

4 years ago

One of Tachi's newly born legacy biotechs raises $135M and enlists an A-list board to advance late-stage vaccine

4 years ago

First page Previous page 641 642 643644645 646 647 Next page Last page